-
June 4, 2021 Biotech Firm PsyBio Therapeutics Is Producing Psilocybin From BacteriaPsyBio Therapeutics is harvesting the psychedelic compound psilocybin from a strain of bacteria instead of...
-
June 4, 2021 Psychedelic Business Spotlight: June 4, 2021This week in psychedelic business: Mindset Pharma's new research, synthetic ibogaine, and the Western Hemisphere...
-
June 3, 2021 New York Bill Proposes State-Sponsored Psychedelic Research InstituteNew York is looking to explore psychedelic research through the formation of a new institute...
-
June 2, 2021 California Senate Passes Psychedelic Decriminalization BillCalifornia is poised to become the second U.S. state to decriminalize possession and use of...
-
June 2, 2021 Cybin Taps First-of-Its-Kind Device to Study Psychedelic Effects of KetamineA new device may help Cybin better understand the psychedelic impact of the drug ketamine...
-
June 2, 2021 ‘PSY’ Becomes First U.S.-Listed Psychedelic ETFDefiance Next Gen Altered Experience ETF began trading Friday on the New York Stock Exchange...
-
May 31, 2021 Why Deepak Chopra Wants to Shift Public Perception About PsychedelicsSpiritual leader and healer Deepak Chopra is focused on bringing attention to psychedelics as a...
-
May 28, 2021 Psychedelic Business Spotlight: May 28, 2021This week in psychedelic business news: NeonMind's Medical Advisory Board, Mynd's public listing, and a...
-
May 26, 2021 Attorneys General, Organizations, Specialists Sue DEA for Access to Psilocybin for Terminally Ill PatientsA coalition of activists, organizations, and attorneys general are suing the DEA on behalf of...
-
May 25, 2021 FDA Approves First-Ever MDMA Study for Therapist Volunteers to Better Treat PTSD PatientsThe FDA has approved a novel study allowing therapists who treat PTSD to take MDMA...
